Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Hims & Hers Health Boosts Outlook. Is This a Golden Opportunity to Buy the Stock?


Although the company reported strong second-quarter results and raised its guidance, shares of Hims & Hers Health (NYSE: HIMS) slipped immediately after its earnings announcement. Nonetheless, the stock has been a strong performer this year, up over 80%.

Let's take a look at the telehealth company's most recent results, and decide whether it still makes sense to buy the stock on this recent pullback.

Hims & Hers continues to see strong growth, with revenue surging 53% to $315.6 million. That was well above the company's guidance for $292 million to $297 million. Its net orders climbed 20% to 2.53 million, while average order value (AOV) climbed 27% to $121.

Continue reading


Source Fool.com

Like: 0
Share

Comments